GleamWall
中文EN

MDXR MEDICAL EXERCISE INC.

Services-Health Services · OTC · SEC CIK 2001249 · Fiscal year ends 03/31

Financial factors as of 2025-03-31 (2025Q4), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY—
TTM EPS YoY—
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin65.6%
Operating margin65.6%
Net margin-25,578.4%
FCF margin-15,061.5%
EBITDA margin953.8%

Returns

ROE—
ROA-507.2%
ROIC (approx.)—
Asset turnover0.02x

Leverage & solvency

Liabilities / assets203.1%
Debt / equity—
Current ratio0.00x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.58x
Accruals ratio-214.5%
Payout ratio—
Capex / revenue299.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q12026-06-302026Q4*2026-03-312026Q32025-12-312026Q22025-09-302026Q12025-06-302025Q4*2025-03-312025Q3*2024-12-312025Q2*2024-09-30
Income statement
Revenue$1,000————$0$0$0
Cost of revenue—————$0$0$0
Gross profit$1,000————$0$0$0
SG&A expense——$18,882$76,497$61,378$72,864$33,241$46,377
Operating income-$52,769-$42,397-$25,823-$83,852-$70,291$264,631-$141,207-$61,923
Pretax income-$52,666-$45,875-$25,823-$84,719-$70,291-$67,592-$141,207-$61,534
Net income-$52,666-$45,875-$25,823-$84,719-$70,291-$67,592-$141,207-$61,534
EBITDA-$52,227-$40,661-$23,882-$81,674-$67,410$267,462-$138,357-$58,979
EPS (basic)0.00——-0.01-0.01—-0.01-0.01
EPS (diluted)0.00——-0.01-0.01—-0.01-0.01
Weighted avg. shares (diluted)13.33M—12.37M12.33M12.29M—12.22M12.17M
Balance sheet
Cash & equivalents$3,089$43,449$40,549$23,358$3,791$450$7,993$12,257
Receivables$1,000———————
Current assets$14,089$43,449$40,549$23,358$3,791$450——
PP&E, net—$15,924$40,039$41,273$57,629$59,903——
Intangibles$2,626$1,957$4,992$4,874$5,201$4,908——
Total assets$16,715$61,330$85,580$69,505$66,621$65,261——
Current liabilities$252,888$244,837$223,212$281,314$193,711$132,560——
Total liabilities$252,888$244,837$223,212$281,314$193,711$132,560——
Shareholders' equity-$236,173-$183,507-$137,632-$211,809-$127,090-$67,299-$6-$64,500
Shares outstanding13.33M13.33M13.33M12.33M12.33M12.22M——
Cash flow statement
Operating cash flow-$46,722-$17,536-$76,791-$21,841-$78,583-$46,597-$41,441-$37,137
Capital expenditure—————$0$0$0
Free cash flow—————-$46,597-$41,441-$37,137
Investing cash flow$6,362$21,936-$825$13,638-$900$0-$650$3,301
Financing cash flow—-$1,500$94,807$27,770$82,824$39,054$37,827$40,256
Depreciation & amortization$542$1,736$1,941$2,178$2,881$2,831$2,850$2,944
Stock-based compensation—$0$0$0$2,000$0——

Free plan shows the latest 8 periods; Pro shows all 9 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.